Physician profile
Heather D Delay
NPI 1790383438
$1,752.67
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,198 · 2022: $554.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $364.27 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.04 | 2021-2022 | |
| Amgen INC. | $256.97 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $200.33 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.98 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $122.48 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $105.66 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $80.05 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.42 | 2021-2022 | |
| Philips North America LLC | $33.22 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.10 | 2021 | |
| Amryt Pharma Holdings LTD | $18.77 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.67 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.16 | 2022 | |
| Cvrx, INC. | $11.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Delay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.